TG Branfalt

New York’s governor has pulled his cannabis legalization plan from the state’s budget, planning instead to let lawmakers address the issue in the next legislative session this summer.

The CVS pharmacy chain is reportedly adding CBD topical products — but not edibles or food additives — to store shelves in eight states.

The Canadian cannabis exchange-traded fund Horizons Life Sciences Index ETF could start adding U.S. firms to its roster of publicly traded cannabis companies.

The House Financial Services Committee is set to vote next week on the SAFE Banking Act; it will be the first Congressional cannabis vote of the year.

San Diego could be the next California city to embrace the licensing of social-use cannabis lounges.

In the first public cannabis listing of 2019, Vireo has listed on the Canadian Securities Exchange in Toronto under the ticker symbol “VREO.”

After it passed several key legislative hurdles, New Jersey lawmakers are set to vote on the state’s pending legalization bill as early as next week.

California cannabis firm Canndescent announced the completion of its solar-powered production facility in Desert Springs.

Grassroots Cannabis in Illinois completed its first capital raise of $90 million; the company is now set to expand facilities in Illinois, Maryland, and Pennsylvania.

The governor’s inclusion of legalization revenues for his 2021 budget suggests that sales could launch in New York by 2020.